BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 9612092)

  • 1. Adjuvant therapy in colorectal cancer.
    Parshad R
    Trop Gastroenterol; 1997; 18(4):139-44. PubMed ID: 9612092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant therapy for colon and rectal cancer.
    Ratkin GA
    Am Fam Physician; 1997 May; 55(7):2487-92, 2495-6. PubMed ID: 9166147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a role for adjuvant therapy in bowel cancer?
    Marsh JC
    J Clin Gastroenterol; 1994 Apr; 18(3):184-8. PubMed ID: 8034911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New adjuvant therapy for colon cancer: justified hope or commercial hype.
    Galanis E; Alberts SR; O'Connell MJ
    Surg Oncol Clin N Am; 2000 Oct; 9(4):813-23; discussion 825-6. PubMed ID: 11008249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
    Taal BG; Van Tinteren H; Zoetmulder FA;
    Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy for colon cancer.
    Ducreux M; Boige V
    Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):283-98. PubMed ID: 11969239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease.
    Benson AB
    Clin Cancer Res; 2007 Nov; 13(22 Pt 2):6913s-20s. PubMed ID: 18006800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapy for resectable rectal and colonic cancer.
    Heriot AG; Kumar D
    Br J Surg; 1998 Mar; 85(3):300-9. PubMed ID: 9529480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group.
    Glimelius B; Dahl O; Cedermark B; Jakobsen A; Bentzen SM; Starkhammar H; Grönberg H; Hultborn R; Albertsson M; Påhlman L; Tveit KM;
    Acta Oncol; 2005; 44(8):904-12. PubMed ID: 16332600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004.
    Cree M; Tonita J; Turner D; Nugent Z; Alvi R; Barss R; King C; Winget M
    Clin Colorectal Cancer; 2009 Jul; 8(3):141-5. PubMed ID: 19632928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
    J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dissent over standards in adjuvant management of colon carcinoma].
    Lorenz M; Waldeyer M; Encke A
    Zentralbl Chir; 1997; 122(4):210-21; discussion 222-3. PubMed ID: 9221629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
    Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
    Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.
    Sobrero A; Frassineti G; Falcone A; Dogliotti L; Rosso R; Di Costanzo F; Bruzzi P;
    Br J Cancer; 2005 Jan; 92(1):24-9. PubMed ID: 15611795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
    Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
    J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy for colon cancer.
    Saltz LB
    Surg Oncol Clin N Am; 2010 Oct; 19(4):819-27. PubMed ID: 20883956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy for colon cancer: evidence on improvement in survival.
    Samantas E; Dervenis C; Rigatos SK
    Dig Dis; 2007; 25(1):67-75. PubMed ID: 17384510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.